Very good. The lack of profit motive is probably why AZ have been so useless at getting regulator approval and instead treated the whole process like a PhD thesis. (View Post)
Given all the additional Pfizer manufacturing capacity being built in Europe, I suspect the EU won't be buying any more AZ after the initial order is complete. With Pfizer having much higher efficacy… (View Post)